ABUS
Arbutus Biopharma Corp
Recent 8-K filings for ABUS
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 13, 2026 11:31 UTC earnings item 2.02item 9.01
Arbutus Q1 net income $169.7M ($0.88/share) on $179.1M revenue from Moderna settlement
source · ABUS on sec.gov